Relmada Therapeutics Inc. Announces First Patient Dosed in Phase 2 Study of REL-1017 in Patients with Major Depressive Disorder
Top-Line Data Expected in First Half of 2019
News
IView Therapeutics Closes its A round financing to move forward IView-1201, a novel sustain release povidone iodine gel forming solution, into phase II clinical trials for the treatment of adenoviral conjunctivitis
AARP, startups partner to study digital healthcare technology
Clinicians and groups like AARP view in-home digital technology as the future healthcare and are studying different technologies to assist patients in home.
CHOP spinout Bainbridge Health raises $1.6 million to expand mission, team
Medical errors remain a significant cause of death in the U.S. This Center City company is looking to combat that through technology.
Hackensack Meridian Health Funds Key Innovation to Improve Health Care in New Jersey
Pillo, a medical hub for home, is the first health care innovation supported by network’s $25 million Innovation Center Fund to improve patient experience and care while reducing costs
Combination of Checkpoint Inhibitors and Intezyne’s Novel Cancer Resistance Pathway Inhibitor IT-139 Shows Enhanced Immune Efficacy
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
IView Therapeutics was awarded SBIR Innovative grant by NIH’s National Institute of Allergy and Infectious Diseases (NIAID)
Data on Cancer Resistance Pathway Inhibitor IT-139 to be Presented at AACR 2018 Annual Meeting
VenatoRx Pharmaceuticals to Present its Lead Clinical Antibacterial Candidate, VNRX-5133, at the American Chemical Society National Meeting